 Risk monitoring randomized trials emergency medicine experience Brain Resuscitation Clinical Trial II Risk monitoring Brain Resuscitation Clinical Trial II multicenter placebo-controlled trial efficacy calcium-entry blocker lidoflazine amelioration brain damage comatose cardiac-arrest survivors unexpected challenges Concern monitoring adverse reactions excess dangerous cardiac arrhythmias lidoflazine group cause problem determine ethical trial in-depth review data outside experts additional data efforts possible causes problem drug administration protocols blood pressure control subsequent arrhythmia rates efficient monitoring system important problem trial major changes